Retrieve available abstracts of 11 articles: HTML format
Single Articles
March 2025
POLANCO FERNANDEZ M, Gangas Barranquero L, Gonzalez-Quintanilla V, Madera Fernandez J, et al [Successful Management of Wearing-off effect with Eptinezumab: Lessons from a
case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies].
Rev Neurol. 2025;80:38974. PubMedAbstract available
November 2024
GARCIA-RON A, Arias-Vivas E, Bote-Gascon M, Gonzalez-Garcia N, et al [Usefulness of spontaneous drawing in the diagnostic guidance of pediatric
patients with headache].
Rev Neurol. 2024;79:265-271. PubMedAbstract available
KLAIC-LOPEZ DA, Paez-Granda D, Romero-Carvajal F [Hemiplegic migraine: classic findings in a rare pathology].
Rev Neurol. 2024;79:263-264. PubMed
September 2024
SANCHEZ-RODRIGUEZ N, Millan-Vazquez M, Fernandez-Panadero A, Gomez-Caminero AE, et al [Management of migraine by hospital emergency departments: a retrospective
observational study carried out at the Hospital Universitario Virgen del Rocio].
Rev Neurol. 2024;79:155-160. PubMedAbstract available
May 2024
GARCIA-ESTEVEZ DA, Juanatey-Garcia A, Rodriguez-Garrido J, Sabbagh-Casado N, et al Reduction of plasma CGRP levels in migraine patients treated with erenumab or
galcanezumab.
Rev Neurol. 2024;78:293-294. PubMed
January 2024
MINGUEZ-OLAONDO A, Lopez-Bravo A, Quintas S, Nieves-Castellanos C, et al [New therapeutic era for migraine attacks with recently approved monoclonal
antibodies, ditans and gepants].
Rev Neurol. 2024;78:47-57. PubMedAbstract available
October 2023
VINUEZA-BUITRON P, Montes-Pena VJ, Rodriguez-Mena D, Boada-Cuellar JL, et al [Habituation deficit study in patients with episodic migraine thru nociceptive
blink reflex].
Rev Neurol. 2023;77:159-165. PubMedAbstract available
June 2023
GUEVARA-MARTINEZ E, Arjona-Padillo A [Complete remission of a migraine after treatment with cisplatin].
Rev Neurol. 2023;76:375. PubMed
May 2023
PEREZ-RODRIGUEZ A, Bandres-Hernandez P, Anciones C, Terron-Cuadrado C, et al [Cardiovascular safety of new drugs for the acute and preventive treatment of
migraine: gepants and ditans].
Rev Neurol. 2023;76:295-308. PubMedAbstract available
April 2023
MADERA J, Rodriguez-Rodriguez EM, Gonzalez-Quintanilla V, Perez-Pereda S, et al [Peripheral stimulation of the trigeminal nerve by nasopharyngeal swabbing as a
possible trigger of migraine attacks].
Rev Neurol. 2023;76:227-233. PubMedAbstract available
March 2023
FRESAN-RESTITUTO D, Lacalle-Fabo E, Martin-Bujanda M, Sarobe-Carricas MT, et al Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit
from a switch to a second one.
Rev Neurol. 2023;76:213-216. PubMed